Resolution of musculoskeletal symptoms in the carcinoid syndrome after treatment with the somatostatin analog octreotide.
Smith
S
S
Vanderbilt University School of Medicine, Nashville, Tennessee.
Anthony
L
L
Roberts
L J
LJ
Oates
J A
JA
Pincus
T
T
D000368:Aged; D001847:Bone Diseases / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy* / Q000209:etiology; D015282:Octreotide / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy / Q000209:etiology
D015282:Octreotide